检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:隋小宇[1] 刘畅[1] 王钧[2] 袁橙[1] 马晓星[1] 刘婷婷[1] 韩翠艳[1]
机构地区:[1]齐齐哈尔医学院药学院,黑龙江齐齐哈尔161006 [2]哈尔滨市第一医院药剂科,哈尔滨150010
出 处:《中国药学杂志》2015年第16期1412-1418,共7页Chinese Pharmaceutical Journal
基 金:齐齐哈尔市科学技术计划项目(SFGG-201340)
摘 要:目的采用高压均质结合冷冻干燥法制备辅酶Q10-γ-环糊精纳晶混悬物,对制备工艺进行优化,并对产品质量进行评价。方法以纳晶混悬物包载率和平均粒径作为评价指标,采用响应面设计法筛选处方及制备工艺,并对产品的稳定性及体外透皮性能进行考察。结果最佳制备条件:γ-环糊精与药物质量比7.76∶1,超声温度40℃,超声时间28.33 min,均质压力40 MPa。此条件下得到纳晶混悬物产品的平均包载率为48.39%,平均粒径324 nm。体外透皮吸收试验测得该纳晶混悬物的稳态渗透速率常数为5.68μg·cm-2·h-1。结论该制备方法简便可行,产品质量稳定,适于工业生产。OBJECTIVE To prepare coenzyme Q10-γ-cyclodextrin nano-crystal suspension using high pressure homogeneous combining freeze-drying method, optimize the preparation technology, and evaluate the quality of the product. METHODS Encapsulation efficiency and mean particle size of inclusion complex were used as indicators, and response surface method was performed for optimizing preparation process and formulations. The stability and transdermal performance in vitro of the inclusion complexes were investigated. RESULTS The optimal technical parameters were as follows : the mass ratio of γ-cyclodextrin and drug, 7.76 : 1 ; uhrasonic temperature, 40℃; ultrasonic time, 28.33 min; homogeneous pressure, 40MPa. Under such conditons, an average encapsulation efficiency of 48.39% and average particle size of 324nm were obtained for the nano-crystal suspension. The transdermal experiment in vitro showed that the infiltration rate of inclusion was 5.68μg·cm^-2·h^-1. CONCLUSION The preparation method is simple and feasible. The product quality is stable. Moreover, it is easy to manufacture.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15